在住院治疗后,脏功能的尿蛋白标记下降
Yumeng Wen1, Steven Menez1, Heather Thiessen Philbrook1
1Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, United States of America.
JCI insight
|August 12, 2025
概括
表明损伤,炎症和纤维化的尿蛋白与住院后功能下降有关. 这项研究确定了关键的蛋白质生物标志物,用于预测风险患者的功能损失.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 蛋白质组学是指蛋白质组学.
- 生物标志物发现发现
背景情况:
- 住院治疗增加了功能下降的风险.
- 尿蛋白学为我们提供了关于这种衰退背后的机制的见解.
- 精密医学项目 (KPMP) 支持病研究.
研究的目的:
- 为了确定与估计的淋巴细胞过率 (eGFR) 在住院后下降相关的尿蛋白.
- 确定这些蛋白质在急性损伤 (AKI) 中是否有差异表达.
- 研究已识别的蛋白质的细胞起源和与病理的相关性.
主要方法:
- 在174名来自ASSESS-AKI队列的患者中,对2783个尿蛋白的奥林克蛋白质分析.
- 蛋白质水平与EGFR下降的关联分析,平均时间为5.1年.
- 在包括KPMP在内的四个独立队列中进行差异表达分析.
- 在AKI患者中,加权相关联网络分析将蛋白质与细胞转录组和其病理学联系起来.
主要成果:
- 387种蛋白质与更快的EGFR衰退有关,10种与更慢的衰退有关.
- 大多数已识别的蛋白质在AKI期间被差异地表达.
- 这些蛋白质中有71%是细胞表达的,在靠近管体,退行性管体,髓状细胞和脑膜细胞中聚集.
- 蛋白质表达与管道损伤,炎症和纤维化相关.
结论:
- 反映损伤,炎症和纤维化的尿蛋白与EGFR下降有关.
- 这些发现突出了预测功能丧失的潜在生物标志物.
- 尿蛋白学可以为住院后的损伤提供机械洞察力.
相关概念视频
Acute Kidney Injury III: Clinical Manifestations
94
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
94
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Urine Studies I: Urinalysis
103
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
103
Serum Studies: Renal Function Tests
45
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
45
Acute Kidney Injury I: Introduction
74
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
74
Nephrotic Syndrome II : Assessment and Medical Management
21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21


